Structured facts
{
"amendment_scope": "rows_as_filed",
"code": "A",
"date": "2026-03-30",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "This Form 4/A is being filed solely to correct the nature of the shares reported as granted on April 1, 2026. This amendment reflects that the shares granted were shares of common stock, rather than restricted stock units.",
"F2": "Including 356,250 shares of common stock granted to the Reporting Person on March 30, 2026 as restricted stock awards, for no consideration. The restricted stock awards vest in full on March 30, 2029, which is the third anniversary of the March 30, 2026 grant date, subject to the Reporting Person\u0027s continued service through such vesting date.",
"F3": "Excludes 121,774 shares controlled by the Reporting Person, through his control of BP Peptides, LLC."
},
"owners": [
{
"cik": "0001687758",
"name": "Lipman Matthew E.",
"roles": [
"director",
"officer",
"ten_percent_owner"
],
"title": "Chief Executive Officer"
}
],
"ownership": "D",
"post_shares": "2920340",
"price": null,
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "356250",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}